Scinai Announces Signing of Loan Restructuring Agreement with European Investment Bank; Converting Approximately $29 million of Debt to Preferred Equity Convertible into 19.5% Common Equity
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameScinai Immunotherapeutics Ltd
-
Registration countryIsrael
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









